AMSTERDAM, the Netherlands—Disappointing many who hoped this large, randomized, double-blind trial would show a clear win, HEART-FID is the latest trial of iron supplementation in heart failure to ...

IV iron dextran was the most cost-effective treatment, yielding 19.26 quality-adjusted life years at a cost of $157,500 vs 19.10 costing $152,900 for oral ferrous sulfate. HealthDay News — Intravenous ...

Intravenous iron reduced iron deficiency more effectively than oral iron, which is often distasteful, among pregnant women in Nigeria. However, no significant difference was found in the prevalence of ...

DENVER—Patients with end-stage renal disease who receive predialysis intravenous iron therapy are more likely to start hemodialysis with higher hemoglobin (Hb) levels and to achieve better Hb control ...

Panelists discuss how IV iron formulations requiring fewer infusion visits tend to have better adherence rates, while the ongoing nursing shortage has created additional challenges in scheduling and ...

The Pathways to Policy and Implementation for FCM (PPI:FCM) initiative will work to introduce and scale up use of intravenous (IV) iron in national health systems, helping to reduce maternal and ...

Intravenous iron associated with significant reduction in 30-day postoperative mortality and morbidity compared with RBC transfusion. HealthDay News — For patients with preoperative iron deficiency ...

Injectafer, made by Daiichi Sankyo, is a ferric carboxymaltose injection treatment for iron deficiency in adult patients with heart failure to improve exercise capacity, according to a June 5 company ...

CHICAGO, Nov. 5, 2022 — Long-term treatment with iron administered intravenously improved symptoms and reduced recurrent hospitalizations among people with heart failure and iron deficiency, according ...

(WASHINGTON, Jan. 8, 2026) — A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In the IRONMAN trial, long-term IV iron supplementation in patients with HF and iron deficiency was ...

IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate. (HealthDay News) — Intravenous (IV) iron dextran is the most cost-effective strategy ...